Changeflow GovPing Pharma & Drug Safety FDA Class II Drug Recall: Acme United Corporation
Urgent Enforcement Added Final

FDA Class II Drug Recall: Acme United Corporation

Favicon for changeflow.com FDA: Drug Recalls Class II
Filed March 11th, 2026
Detected March 23rd, 2026
Email

Summary

The FDA has announced an ongoing Class II drug recall initiated by Acme United Corporation for Med Nap BZK Antiseptic Towelettes. The recall is due to CGMP deviations and affects nationwide distribution within the United States.

What changed

The U.S. Food and Drug Administration (FDA) has reported an ongoing Class II drug recall initiated voluntarily by Acme United Corporation. The recall concerns Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) due to Current Good Manufacturing Practice (CGMP) deviations. The affected product was distributed nationwide within the United States.

Companies involved in drug manufacturing should be aware of this recall and the reasons cited (CGMP deviations). While this is a voluntary recall, it highlights the importance of adhering to manufacturing standards. Compliance officers should review their internal CGMP practices and ensure robust quality control measures are in place to prevent similar issues. No specific compliance deadline is mentioned for other entities, but the recall itself is ongoing.

What to do next

  1. Review internal CGMP practices for antiseptic towelettes
  2. Ensure robust quality control measures are in place

Source document (simplified)

json
{
"meta": {
"disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
"terms": "https://open.fda.gov/terms/",
"license": "https://open.fda.gov/license/",
"last_updated": "2026-03-18",
"results": {
"skip": 0,
"limit": 1,
"total": 1
}
},
"results": [
{
"status": "Ongoing",
"city": "Shelton",
"state": "CT",
"country": "United States",
"classification": "Class II",
"openfda": {
"application_number": [
"M003"
],
"brand_name": [
"MED NAP BENZALKONIUM CHLORIDE ANTISEPTIC"
],
"generic_name": [
"BENZALKONIUM CHLORIDE"
],
"manufacturer_name": [
"Acme United Corporation"
],
"product_ndc": [
"0924-0246"
],
"product_type": [
"HUMAN OTC DRUG"
],
"route": [
"TOPICAL"
],
"substance_name": [
"BENZALKONIUM CHLORIDE"
],
"spl_id": [
"2682a042-f9ba-30dc-e063-6394a90a9e33"
],
"spl_set_id": [
"d7c404c1-c765-a67c-e053-2995a90a6b8e"
],
"package_ndc": [
"0924-0246-00",
"0924-0246-01",
"0924-0246-02",
"0924-0246-03"
],
"is_original_packager": [
true
],
"upc": [
"0092265940061"
],
"unii": [
"F5UM2KM3W7"
]
},
"product_type": "Drugs",
"event_id": "98291",
"recalling_firm": "ACME UNITED CORPORATION",
"address_1": "1 Waterview Dr Ste 200",
"address_2": "N/A",
"postal_code": "06484-4368",
"voluntary_mandated": "Voluntary: Firm initiated",
"initial_firm_notification": "Letter",
"distribution_pattern": "Nationwide within the United States",
"recall_number": "D-0366-2026",
"product_description": "Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manufactured by: Acme United Corporation, 1 Waterview Dr, Shelton, CT 06481, NDC 0924-0246-01.",
"product_quantity": "N/A",
"reason_for_recall": "CGMP Deviations",
"recall_initiation_date": "20260120",
"center_classification_date": "20260302",
"report_date": "20260311",
"code_info": "Lot #: MN09322, Exp. Date Mar 2027; MN15222, Exp. Date May 2027; MN21622, Exp. Date Jul 2027; MN31822, Exp. Date Oct 2027; MN06223, MN06323, Exp. Date Feb 2028; MN12523, Exp. Date Apr 2028; MN16123, Exp. Date May 2028; MN20523, MN20623, MN20723, Exp. Date Jun 2028; MN23223, Exp. Date Jul 2028; MN31123, Exp. Date Oct 2028; MN300524, MN300624 MN302624, MN302724, MN303324, Exp. Date Dec 2028."
}
]
}

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 11th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
D-0366-2026

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Recalls CGMP Compliance
Threshold
Class II
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Product Safety Public Health

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Drug Recalls Class II publishes new changes.

Free. Unsubscribe anytime.